☆ 4.6 Letter

MYD88 (L265P) mutation is associated with an unfavourable outcome of primary central nervous system lymphoma

BRITISH JOURNAL OF HAEMATOLOGY (2017)

Get Full Text
Add to Collection

Journal

BRITISH JOURNAL OF HAEMATOLOGY
Volume 177, Issue 3, Pages 492-494

Publisher

WILEY
DOI: 10.1111/bjh.14080

Keywords

clinical sequencing; MYD88 mutation; primary central nervous system lymphoma; targeted sequencing

Categories

Hematology

Funding

  1. Grants-in-Aid for Scientific Research [16H02660] Funding Source: KAKEN

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.